Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00091390 · ClinicalTrials.gov registry record · Phase 2
Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
A Phase 2 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 129
- Enrollment target
NCT00091390 is a Phase 2 study that has completed, run by Radiation Therapy Oncology Group. The registered enrollment target is 129 participants.
The verdict
NCT00091390, a Phase 2 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 129 participants
- Enrollment target
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays and other sources to damage tumor cells. Internal radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. Giving radiation therapy in different ways may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving internal radiation therapy together with external-beam radiation therapy works in treating patients with stage II or stage III prostate cancer.
Interventions
- RADIATION External beam radiotherapy
- RADIATION High Dose brachytherapy boost
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2004-07 |
| Est. Completion | 2016-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00091390
The ClinicalTrials.gov registry entry for NCT00091390 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which External beam radiotherapy is the first listed.
NCT00091390 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00091390 about?
NCT00091390 is a clinical study titled "Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer". RATIONALE: Radiation therapy uses high-energy x-rays and other sources to damage tumor cells. Internal radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. Giving radiation therapy in different ways may kill more tumor cells. PURPOSE: This phase II t...
What is the current status of trial NCT00091390?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 129 participants. The study started on 2004-07. Estimated completion is 2016-12.
What interventions are being tested in trial NCT00091390?
The interventions under investigation include: External beam radiotherapy (RADIATION), High Dose brachytherapy boost (RADIATION).
Who is sponsoring clinical trial NCT00091390?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.